Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384370 · ClinicalTrials.gov registry record
APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 1,260
- Enrollment target
NCT01384370 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 1,260 participants.
The verdict
NCT01384370 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 1,260 participants
- Enrollment target
Study Summary
In both the ASC-US Study and Adjunct Study populations, the objectives are to: * evaluate the performance characteristics of the AHPV-GT Assay for detecting cervical disease in women with APTIMA HPV Assay positive results and * evaluate the ability of the AHPV-GT Assay to detect HPV high-risk types 16, 18, and 45 in women with APTIMA HPV Assay positive results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,260 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01384370
The ClinicalTrials.gov registry entry for NCT01384370 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gen-Probe, Incorporated, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01384370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01384370 about?
NCT01384370 is a clinical study titled "APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results". In both the ASC-US Study and Adjunct Study populations, the objectives are to: * evaluate the performance characteristics of the AHPV-GT Assay for detecting cervical disease in women with APTIMA HPV Assay positive results and * evaluate the ability of the AHPV-GT Assay to detect HPV high-risk types...
What is the current status of trial NCT01384370?
This trial is currently completed. The enrollment target is 1,260 participants. The study started on 2011-06. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01384370?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.